 | • レポートコード：MRC308GR11615 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の創傷止血パウダーの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の創傷止血パウダー市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 創傷止血パウダーの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
創傷止血パウダー市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・植物性止血パウダー、ゼラチン性止血パウダー、その他
用途別セグメント
・病院、診療所、手術センター、家庭、その他
主要な市場プレーヤー
・Pfizer、BD、Johnson & Johnson、MedTrade Products、C. R. Bard、Equimedical、MBP、Celox、Ferrosan Medical Devices、Betatech Medical、BioCer Entwicklungs、Hemostasis、Aegis Lifesciences、CSL Behring、Gelita Medical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、創傷止血パウダー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な創傷止血パウダーメーカーの企業概要、2019年～2022年までの創傷止血パウダーの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な創傷止血パウダーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別創傷止血パウダーの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの創傷止血パウダーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での創傷止血パウダー市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および創傷止血パウダーの産業チェーンを掲載しています。
・第14、15章では、創傷止血パウダーの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 創傷止血パウダーの概要
– 種類別分析（2018年vs2022年vs2029年）：植物性止血パウダー、ゼラチン性止血パウダー、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、手術センター、家庭、その他
– 世界の創傷止血パウダー市場規模・予測
– 世界の創傷止血パウダー生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Pfizer、BD、Johnson & Johnson、MedTrade Products、C. R. Bard、Equimedical、MBP、Celox、Ferrosan Medical Devices、Betatech Medical、BioCer Entwicklungs、Hemostasis、Aegis Lifesciences、CSL Behring、Gelita Medical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：植物性止血パウダー、ゼラチン性止血パウダー、その他
・用途別分析2018年-2029年：病院、診療所、手術センター、家庭、その他
・創傷止血パウダーの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・創傷止血パウダーのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・創傷止血パウダーのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・創傷止血パウダーの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・創傷止血パウダーの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Wound Hemostatic Powder
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Wound Hemostatic Powder Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Plant Hemostatic Powder
1.3.3 Gelatin Hemostatic Powder
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Wound Hemostatic Powder Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Surgery Center
1.4.5 Household
1.4.6 Others
1.5 Global Wound Hemostatic Powder Market Size & Forecast
1.5.1 Global Wound Hemostatic Powder Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Wound Hemostatic Powder Sales Quantity (2018-2029)
1.5.3 Global Wound Hemostatic Powder Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Wound Hemostatic Powder Product and Services
2.1.4 Pfizer Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Wound Hemostatic Powder Product and Services
2.2.4 BD Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 BD Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson Wound Hemostatic Powder Product and Services
2.3.4 Johnson & Johnson Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 MedTrade Products
2.4.1 MedTrade Products Details
2.4.2 MedTrade Products Major Business
2.4.3 MedTrade Products Wound Hemostatic Powder Product and Services
2.4.4 MedTrade Products Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 MedTrade Products Recent Developments/Updates
2.5 C. R. Bard
2.5.1 C. R. Bard Details
2.5.2 C. R. Bard Major Business
2.5.3 C. R. Bard Wound Hemostatic Powder Product and Services
2.5.4 C. R. Bard Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 C. R. Bard Recent Developments/Updates
2.6 Equimedical
2.6.1 Equimedical Details
2.6.2 Equimedical Major Business
2.6.3 Equimedical Wound Hemostatic Powder Product and Services
2.6.4 Equimedical Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Equimedical Recent Developments/Updates
2.7 MBP
2.7.1 MBP Details
2.7.2 MBP Major Business
2.7.3 MBP Wound Hemostatic Powder Product and Services
2.7.4 MBP Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MBP Recent Developments/Updates
2.8 Celox
2.8.1 Celox Details
2.8.2 Celox Major Business
2.8.3 Celox Wound Hemostatic Powder Product and Services
2.8.4 Celox Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Celox Recent Developments/Updates
2.9 Ferrosan Medical Devices
2.9.1 Ferrosan Medical Devices Details
2.9.2 Ferrosan Medical Devices Major Business
2.9.3 Ferrosan Medical Devices Wound Hemostatic Powder Product and Services
2.9.4 Ferrosan Medical Devices Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Ferrosan Medical Devices Recent Developments/Updates
2.10 Betatech Medical
2.10.1 Betatech Medical Details
2.10.2 Betatech Medical Major Business
2.10.3 Betatech Medical Wound Hemostatic Powder Product and Services
2.10.4 Betatech Medical Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Betatech Medical Recent Developments/Updates
2.11 BioCer Entwicklungs
2.11.1 BioCer Entwicklungs Details
2.11.2 BioCer Entwicklungs Major Business
2.11.3 BioCer Entwicklungs Wound Hemostatic Powder Product and Services
2.11.4 BioCer Entwicklungs Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 BioCer Entwicklungs Recent Developments/Updates
2.12 Hemostasis
2.12.1 Hemostasis Details
2.12.2 Hemostasis Major Business
2.12.3 Hemostasis Wound Hemostatic Powder Product and Services
2.12.4 Hemostasis Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hemostasis Recent Developments/Updates
2.13 Aegis Lifesciences
2.13.1 Aegis Lifesciences Details
2.13.2 Aegis Lifesciences Major Business
2.13.3 Aegis Lifesciences Wound Hemostatic Powder Product and Services
2.13.4 Aegis Lifesciences Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Aegis Lifesciences Recent Developments/Updates
2.14 CSL Behring
2.14.1 CSL Behring Details
2.14.2 CSL Behring Major Business
2.14.3 CSL Behring Wound Hemostatic Powder Product and Services
2.14.4 CSL Behring Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 CSL Behring Recent Developments/Updates
2.15 Gelita Medical
2.15.1 Gelita Medical Details
2.15.2 Gelita Medical Major Business
2.15.3 Gelita Medical Wound Hemostatic Powder Product and Services
2.15.4 Gelita Medical Wound Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Gelita Medical Recent Developments/Updates
3 Competitive Environment: Wound Hemostatic Powder by Manufacturer
3.1 Global Wound Hemostatic Powder Sales Quantity by Manufacturer (2018-2023)
3.2 Global Wound Hemostatic Powder Revenue by Manufacturer (2018-2023)
3.3 Global Wound Hemostatic Powder Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Wound Hemostatic Powder by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Wound Hemostatic Powder Manufacturer Market Share in 2022
3.4.2 Top 6 Wound Hemostatic Powder Manufacturer Market Share in 2022
3.5 Wound Hemostatic Powder Market: Overall Company Footprint Analysis
3.5.1 Wound Hemostatic Powder Market: Region Footprint
3.5.2 Wound Hemostatic Powder Market: Company Product Type Footprint
3.5.3 Wound Hemostatic Powder Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Wound Hemostatic Powder Market Size by Region
4.1.1 Global Wound Hemostatic Powder Sales Quantity by Region (2018-2029)
4.1.2 Global Wound Hemostatic Powder Consumption Value by Region (2018-2029)
4.1.3 Global Wound Hemostatic Powder Average Price by Region (2018-2029)
4.2 North America Wound Hemostatic Powder Consumption Value (2018-2029)
4.3 Europe Wound Hemostatic Powder Consumption Value (2018-2029)
4.4 Asia-Pacific Wound Hemostatic Powder Consumption Value (2018-2029)
4.5 South America Wound Hemostatic Powder Consumption Value (2018-2029)
4.6 Middle East and Africa Wound Hemostatic Powder Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Wound Hemostatic Powder Sales Quantity by Type (2018-2029)
5.2 Global Wound Hemostatic Powder Consumption Value by Type (2018-2029)
5.3 Global Wound Hemostatic Powder Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Wound Hemostatic Powder Sales Quantity by Application (2018-2029)
6.2 Global Wound Hemostatic Powder Consumption Value by Application (2018-2029)
6.3 Global Wound Hemostatic Powder Average Price by Application (2018-2029)
7 North America
7.1 North America Wound Hemostatic Powder Sales Quantity by Type (2018-2029)
7.2 North America Wound Hemostatic Powder Sales Quantity by Application (2018-2029)
7.3 North America Wound Hemostatic Powder Market Size by Country
7.3.1 North America Wound Hemostatic Powder Sales Quantity by Country (2018-2029)
7.3.2 North America Wound Hemostatic Powder Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Wound Hemostatic Powder Sales Quantity by Type (2018-2029)
8.2 Europe Wound Hemostatic Powder Sales Quantity by Application (2018-2029)
8.3 Europe Wound Hemostatic Powder Market Size by Country
8.3.1 Europe Wound Hemostatic Powder Sales Quantity by Country (2018-2029)
8.3.2 Europe Wound Hemostatic Powder Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Wound Hemostatic Powder Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Wound Hemostatic Powder Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Wound Hemostatic Powder Market Size by Region
9.3.1 Asia-Pacific Wound Hemostatic Powder Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Wound Hemostatic Powder Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Wound Hemostatic Powder Sales Quantity by Type (2018-2029)
10.2 South America Wound Hemostatic Powder Sales Quantity by Application (2018-2029)
10.3 South America Wound Hemostatic Powder Market Size by Country
10.3.1 South America Wound Hemostatic Powder Sales Quantity by Country (2018-2029)
10.3.2 South America Wound Hemostatic Powder Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Wound Hemostatic Powder Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Wound Hemostatic Powder Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Wound Hemostatic Powder Market Size by Country
11.3.1 Middle East & Africa Wound Hemostatic Powder Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Wound Hemostatic Powder Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Wound Hemostatic Powder Market Drivers
12.2 Wound Hemostatic Powder Market Restraints
12.3 Wound Hemostatic Powder Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Wound Hemostatic Powder and Key Manufacturers
13.2 Manufacturing Costs Percentage of Wound Hemostatic Powder
13.3 Wound Hemostatic Powder Production Process
13.4 Wound Hemostatic Powder Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Wound Hemostatic Powder Typical Distributors
14.3 Wound Hemostatic Powder Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Wound Hemostatic Powder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Wound Hemostatic Powder Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Wound Hemostatic Powder Product and Services
Table 6. Pfizer Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. BD Basic Information, Manufacturing Base and Competitors
Table 9. BD Major Business
Table 10. BD Wound Hemostatic Powder Product and Services
Table 11. BD Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. BD Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson Wound Hemostatic Powder Product and Services
Table 16. Johnson & Johnson Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. MedTrade Products Basic Information, Manufacturing Base and Competitors
Table 19. MedTrade Products Major Business
Table 20. MedTrade Products Wound Hemostatic Powder Product and Services
Table 21. MedTrade Products Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. MedTrade Products Recent Developments/Updates
Table 23. C. R. Bard Basic Information, Manufacturing Base and Competitors
Table 24. C. R. Bard Major Business
Table 25. C. R. Bard Wound Hemostatic Powder Product and Services
Table 26. C. R. Bard Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. C. R. Bard Recent Developments/Updates
Table 28. Equimedical Basic Information, Manufacturing Base and Competitors
Table 29. Equimedical Major Business
Table 30. Equimedical Wound Hemostatic Powder Product and Services
Table 31. Equimedical Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Equimedical Recent Developments/Updates
Table 33. MBP Basic Information, Manufacturing Base and Competitors
Table 34. MBP Major Business
Table 35. MBP Wound Hemostatic Powder Product and Services
Table 36. MBP Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. MBP Recent Developments/Updates
Table 38. Celox Basic Information, Manufacturing Base and Competitors
Table 39. Celox Major Business
Table 40. Celox Wound Hemostatic Powder Product and Services
Table 41. Celox Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Celox Recent Developments/Updates
Table 43. Ferrosan Medical Devices Basic Information, Manufacturing Base and Competitors
Table 44. Ferrosan Medical Devices Major Business
Table 45. Ferrosan Medical Devices Wound Hemostatic Powder Product and Services
Table 46. Ferrosan Medical Devices Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Ferrosan Medical Devices Recent Developments/Updates
Table 48. Betatech Medical Basic Information, Manufacturing Base and Competitors
Table 49. Betatech Medical Major Business
Table 50. Betatech Medical Wound Hemostatic Powder Product and Services
Table 51. Betatech Medical Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Betatech Medical Recent Developments/Updates
Table 53. BioCer Entwicklungs Basic Information, Manufacturing Base and Competitors
Table 54. BioCer Entwicklungs Major Business
Table 55. BioCer Entwicklungs Wound Hemostatic Powder Product and Services
Table 56. BioCer Entwicklungs Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. BioCer Entwicklungs Recent Developments/Updates
Table 58. Hemostasis Basic Information, Manufacturing Base and Competitors
Table 59. Hemostasis Major Business
Table 60. Hemostasis Wound Hemostatic Powder Product and Services
Table 61. Hemostasis Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hemostasis Recent Developments/Updates
Table 63. Aegis Lifesciences Basic Information, Manufacturing Base and Competitors
Table 64. Aegis Lifesciences Major Business
Table 65. Aegis Lifesciences Wound Hemostatic Powder Product and Services
Table 66. Aegis Lifesciences Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Aegis Lifesciences Recent Developments/Updates
Table 68. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 69. CSL Behring Major Business
Table 70. CSL Behring Wound Hemostatic Powder Product and Services
Table 71. CSL Behring Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. CSL Behring Recent Developments/Updates
Table 73. Gelita Medical Basic Information, Manufacturing Base and Competitors
Table 74. Gelita Medical Major Business
Table 75. Gelita Medical Wound Hemostatic Powder Product and Services
Table 76. Gelita Medical Wound Hemostatic Powder Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Gelita Medical Recent Developments/Updates
Table 78. Global Wound Hemostatic Powder Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 79. Global Wound Hemostatic Powder Revenue by Manufacturer (2018-2023) & (USD Million)
Table 80. Global Wound Hemostatic Powder Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 81. Market Position of Manufacturers in Wound Hemostatic Powder, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 82. Head Office and Wound Hemostatic Powder Production Site of Key Manufacturer
Table 83. Wound Hemostatic Powder Market: Company Product Type Footprint
Table 84. Wound Hemostatic Powder Market: Company Product Application Footprint
Table 85. Wound Hemostatic Powder New Market Entrants and Barriers to Market Entry
Table 86. Wound Hemostatic Powder Mergers, Acquisition, Agreements, and Collaborations
Table 87. Global Wound Hemostatic Powder Sales Quantity by Region (2018-2023) & (K Units)
Table 88. Global Wound Hemostatic Powder Sales Quantity by Region (2024-2029) & (K Units)
Table 89. Global Wound Hemostatic Powder Consumption Value by Region (2018-2023) & (USD Million)
Table 90. Global Wound Hemostatic Powder Consumption Value by Region (2024-2029) & (USD Million)
Table 91. Global Wound Hemostatic Powder Average Price by Region (2018-2023) & (US$/Unit)
Table 92. Global Wound Hemostatic Powder Average Price by Region (2024-2029) & (US$/Unit)
Table 93. Global Wound Hemostatic Powder Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Global Wound Hemostatic Powder Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Global Wound Hemostatic Powder Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Global Wound Hemostatic Powder Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Global Wound Hemostatic Powder Average Price by Type (2018-2023) & (US$/Unit)
Table 98. Global Wound Hemostatic Powder Average Price by Type (2024-2029) & (US$/Unit)
Table 99. Global Wound Hemostatic Powder Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Global Wound Hemostatic Powder Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Global Wound Hemostatic Powder Consumption Value by Application (2018-2023) & (USD Million)
Table 102. Global Wound Hemostatic Powder Consumption Value by Application (2024-2029) & (USD Million)
Table 103. Global Wound Hemostatic Powder Average Price by Application (2018-2023) & (US$/Unit)
Table 104. Global Wound Hemostatic Powder Average Price by Application (2024-2029) & (US$/Unit)
Table 105. North America Wound Hemostatic Powder Sales Quantity by Type (2018-2023) & (K Units)
Table 106. North America Wound Hemostatic Powder Sales Quantity by Type (2024-2029) & (K Units)
Table 107. North America Wound Hemostatic Powder Sales Quantity by Application (2018-2023) & (K Units)
Table 108. North America Wound Hemostatic Powder Sales Quantity by Application (2024-2029) & (K Units)
Table 109. North America Wound Hemostatic Powder Sales Quantity by Country (2018-2023) & (K Units)
Table 110. North America Wound Hemostatic Powder Sales Quantity by Country (2024-2029) & (K Units)
Table 111. North America Wound Hemostatic Powder Consumption Value by Country (2018-2023) & (USD Million)
Table 112. North America Wound Hemostatic Powder Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Europe Wound Hemostatic Powder Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Europe Wound Hemostatic Powder Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Europe Wound Hemostatic Powder Sales Quantity by Application (2018-2023) & (K Units)
Table 116. Europe Wound Hemostatic Powder Sales Quantity by Application (2024-2029) & (K Units)
Table 117. Europe Wound Hemostatic Powder Sales Quantity by Country (2018-2023) & (K Units)
Table 118. Europe Wound Hemostatic Powder Sales Quantity by Country (2024-2029) & (K Units)
Table 119. Europe Wound Hemostatic Powder Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Wound Hemostatic Powder Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Wound Hemostatic Powder Sales Quantity by Type (2018-2023) & (K Units)
Table 122. Asia-Pacific Wound Hemostatic Powder Sales Quantity by Type (2024-2029) & (K Units)
Table 123. Asia-Pacific Wound Hemostatic Powder Sales Quantity by Application (2018-2023) & (K Units)
Table 124. Asia-Pacific Wound Hemostatic Powder Sales Quantity by Application (2024-2029) & (K Units)
Table 125. Asia-Pacific Wound Hemostatic Powder Sales Quantity by Region (2018-2023) & (K Units)
Table 126. Asia-Pacific Wound Hemostatic Powder Sales Quantity by Region (2024-2029) & (K Units)
Table 127. Asia-Pacific Wound Hemostatic Powder Consumption Value by Region (2018-2023) & (USD Million)
Table 128. Asia-Pacific Wound Hemostatic Powder Consumption Value by Region (2024-2029) & (USD Million)
Table 129. South America Wound Hemostatic Powder Sales Quantity by Type (2018-2023) & (K Units)
Table 130. South America Wound Hemostatic Powder Sales Quantity by Type (2024-2029) & (K Units)
Table 131. South America Wound Hemostatic Powder Sales Quantity by Application (2018-2023) & (K Units)
Table 132. South America Wound Hemostatic Powder Sales Quantity by Application (2024-2029) & (K Units)
Table 133. South America Wound Hemostatic Powder Sales Quantity by Country (2018-2023) & (K Units)
Table 134. South America Wound Hemostatic Powder Sales Quantity by Country (2024-2029) & (K Units)
Table 135. South America Wound Hemostatic Powder Consumption Value by Country (2018-2023) & (USD Million)
Table 136. South America Wound Hemostatic Powder Consumption Value by Country (2024-2029) & (USD Million)
Table 137. Middle East & Africa Wound Hemostatic Powder Sales Quantity by Type (2018-2023) & (K Units)
Table 138. Middle East & Africa Wound Hemostatic Powder Sales Quantity by Type (2024-2029) & (K Units)
Table 139. Middle East & Africa Wound Hemostatic Powder Sales Quantity by Application (2018-2023) & (K Units)
Table 140. Middle East & Africa Wound Hemostatic Powder Sales Quantity by Application (2024-2029) & (K Units)
Table 141. Middle East & Africa Wound Hemostatic Powder Sales Quantity by Region (2018-2023) & (K Units)
Table 142. Middle East & Africa Wound Hemostatic Powder Sales Quantity by Region (2024-2029) & (K Units)
Table 143. Middle East & Africa Wound Hemostatic Powder Consumption Value by Region (2018-2023) & (USD Million)
Table 144. Middle East & Africa Wound Hemostatic Powder Consumption Value by Region (2024-2029) & (USD Million)
Table 145. Wound Hemostatic Powder Raw Material
Table 146. Key Manufacturers of Wound Hemostatic Powder Raw Materials
Table 147. Wound Hemostatic Powder Typical Distributors
Table 148. Wound Hemostatic Powder Typical Customers
List of Figures
Figure 1. Wound Hemostatic Powder Picture
Figure 2. Global Wound Hemostatic Powder Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Wound Hemostatic Powder Consumption Value Market Share by Type in 2022
Figure 4. Plant Hemostatic Powder Examples
Figure 5. Gelatin Hemostatic Powder Examples
Figure 6. Others Examples
Figure 7. Global Wound Hemostatic Powder Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Wound Hemostatic Powder Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Clinic Examples
Figure 11. Surgery Center Examples
Figure 12. Household Examples
Figure 13. Others Examples
Figure 14. Global Wound Hemostatic Powder Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Wound Hemostatic Powder Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Wound Hemostatic Powder Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Wound Hemostatic Powder Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Wound Hemostatic Powder Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Wound Hemostatic Powder Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Wound Hemostatic Powder by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Wound Hemostatic Powder Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Wound Hemostatic Powder Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Wound Hemostatic Powder Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Wound Hemostatic Powder Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Wound Hemostatic Powder Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Wound Hemostatic Powder Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Wound Hemostatic Powder Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Wound Hemostatic Powder Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Wound Hemostatic Powder Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Wound Hemostatic Powder Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Wound Hemostatic Powder Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Wound Hemostatic Powder Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Wound Hemostatic Powder Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Wound Hemostatic Powder Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Wound Hemostatic Powder Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Wound Hemostatic Powder Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Wound Hemostatic Powder Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Wound Hemostatic Powder Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Wound Hemostatic Powder Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Wound Hemostatic Powder Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Wound Hemostatic Powder Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Wound Hemostatic Powder Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Wound Hemostatic Powder Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Wound Hemostatic Powder Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Wound Hemostatic Powder Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Wound Hemostatic Powder Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Wound Hemostatic Powder Consumption Value Market Share by Region (2018-2029)
Figure 56. China Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Wound Hemostatic Powder Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Wound Hemostatic Powder Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Wound Hemostatic Powder Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Wound Hemostatic Powder Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Wound Hemostatic Powder Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Wound Hemostatic Powder Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Wound Hemostatic Powder Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Wound Hemostatic Powder Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Wound Hemostatic Powder Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Wound Hemostatic Powder Market Drivers
Figure 77. Wound Hemostatic Powder Market Restraints
Figure 78. Wound Hemostatic Powder Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Wound Hemostatic Powder in 2022
Figure 81. Manufacturing Process Analysis of Wound Hemostatic Powder
Figure 82. Wound Hemostatic Powder Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source